Skip to content

Clinical trials

Observational Parkinsonian Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinsonian Disorders Phase: Observational Clear all

76 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20043
20062
20082
20092
20113
20125
20133
20154
20161
20176
20182
20194
20206
20219
20223
20234
20246
20255
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Recruiting14
Unknown status12
Active, not recruiting6
Withdrawn4
Enrolling by invitation3
Not yet recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Neurological Disorders and Stroke (NINDS)5
Fondazione Don Carlo Gnocchi ETS3
Institute for Neurodegenerative Disorders3
University College, London3
National Heart, Lung, and Blood Institute (NHLBI)2
Ruijin Hospital2
University of Oviedo2
Abant Izzet Baysal University1
Ahram Canadian University1
Assiut University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinsonian Disorders76
Parkinson Disease62
Supranuclear Palsy, Progressive13
Multiple System Atrophy11
Neurodegenerative Diseases9
Corticobasal Degeneration7
Disease6
Movement Disorders6
Alzheimer Disease5
Cognitive Dysfunction5

Trials

Showing 26 to 50 of 76. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.